NCT01332552 · Interventional trial
A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
Overall registry status Terminated
Phase 1
Conditions Hepatitis C
Delaware Valley sites
- GSK Investigational Site · Willingboro, NJ · Burlington County
First posted
Registry updated
Added to the directory